InvestorsHub Logo
icon url

andrewflying

12/16/15 9:58 PM

#15013 RE: PJO #15012

Does it have anything to do with AEZS? Seems not.
icon url

chmcnfunds

12/17/15 8:00 AM

#15016 RE: PJO #15012

Transaction confirmed today:

"AstraZeneca enhances long-term growth through Oncology investment in Acerta Pharma

17 December 2015

Transaction includes late-stage, potential best-in-class irreversible small molecule BTK inhibitor, acalabrutinib

Opportunity for first regulatory submissions in haematological malignancies in 2016

Investment establishes in-house expertise in blood cancers and complements strategic use of immunotherapy in haematological malignancies and solid tumours

17 December 2015
__________________________________________________

Not AEZS.